 |
| Global Hospital Acquired Disease Testing Market |
Hospital-acquired
diseases are those infections that are acquired by the
patient under medical care. The most common type of hospital-acquired
infections are urinary tract infection, bloodstream infections, MRSA,
pneumococcal infections, and gastrointestinal illnesses. An
increasing rate of morbidity related to hospital-acquired infections
worldwide is the major driver for the growth of hospital-acquired
disease testing market. Devices employed in modern care facilities,
such as catheters and ventilators are also associated with the cause
of these infections.
Download
PDF Copy of this Business Report @
https://www.coherentmarketinsights.com/insight/request-pdf/992
Market
Dynamics:
According
to World health organization (WHO), 2011, highest prevalence of
hospital-acquired infections occur in intensive care units,
orthopedic, and acute surgical ward. According to an article in
Journal of Nursing & Health Sciences, 2016, the prevalence rate
of hospital-acquired diseases is approximately 5.1% to 11.6% in
emerging economies. Around 1.7 million people are affected by HAI in
the U.S. itself accounting for 9.9 infections per 1000 patients a
day. High prevalence rate is the key factor propelling the growth of
market in near future.
Urinary
tract infection is the most common infection, owing to its high risk
in the patients indwelling with urinary catheter, which leads to
increase chance of bacterial invasion from the anus to the urinary
tract and promotes colonization of bacteria.
The
most common techniques used for diagnosis of the hospital-associated
infections are solid phase hybridization, PCR, and microarrays.
Curetis Unyvero System, launched in 2012, a new molecular device used
for rapid detection microorganism and antibiotic resistance gene.
Antibiotic resistance is also the major concern factor associated
with hospital-acquired Disease testing.
Antibodies
resistance and extended hospitalization is expected to propel growth
of hospital acquired disease testing in the near future
High
prevalence of nosocomial infections such as surgical wounds, urinary
tract infections, and lower respiratory tract infections in intensive
care units, orthopedic, and acute surgical ward fuels growth of
hospital acquired disease testing market. The technique used for
preventions, diagnosis, and testing of hospital acquired diseases are
microarray, PCR, and solid phase hybridization. The urinary tract
infections is most common in patients dwelling with urinary catheter,
as urethra is located close to the anus, which increases the changes
of invasions of bacteria from large intestine into the urinary
tracts. Therefore, expenses and antibiotic resistance increases with
extended hospitalization, which in turn propels growth of hospital
acquired disease testing market.
The
key market players are,
-
Diatherix laboratories
-
Life technologies
-
Cantel Medical Corporation Meridian Biosciences
-
Qiagen GmbH
-
Nordion
-
Roche
-
Cepheid & others
Detailed
Segmentation:
Global
Hospital-acquired Disease Testing market, By Test Type :
•
Urinary Tract Infection
•
Surgical Site Infection
•
Pneumonia Stents
•
Blood Stream Infection
•
Methicillin-resistant Staphylococcus Aureus
•
Others
Global
Hospital-acquired Disease Testing market, By Geography:
•
North America
•
Europe
•
Asia Pacific
•
Latin America
•
Middle East
•
Africa
Ask
For Discount Before Purchase @
https://www.coherentmarketinsights.com/insight/request-discount/992
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
0 comments:
Post a Comment